Breaking News
"I've Always Gotten Along with President Putin" | Trump's TED Talk on War and Frie
The court is calling: How pickleball is rewiring brains, one volley at a time
SpaceX aims to launch Starship Flight 10 test flight on Aug. 24
What is Peter Thiel's Role In The Technocratic Takeover Of Washington?
Top Tech News
Chinese Scientists Produce 'Impossible' Steel to Line Nuclear Fusion Reactors in Major Break
1,000 miles: EV range world record demolished ... by a pickup truck
Fermented Stevia Extract Kills Pancreatic Cancer Cells In Lab Tests
3D printing set to slash nuclear plant build times & costs
You can design the wheels for NASA's next moon vehicle with the 'Rock and Roll Challenge
'Robot skin' beats human reflexes, transforms grip with fabric-powered touch
World's first nuclear fusion plant being built in US to power Microsoft data centers
The mitochondria are more than just the "powerhouse of the cell" – they initiate immune...
Historic Aviation Engine Advance to Unlock Hypersonic Mach 10 Planes
OpenAI CEO Sam Altman Pitches Eyeball-Scanning World ID to Bankers
Anti-Aging Researcher David Sinclair Takes Metformin, NMN, NAD for Longevity
In 2013, GlaxoSmithKline shutdown Sirtris (David Sinclair's company) about five years after spending $720 million to buy Sirtris.
David A. Sinclair, Ph.D., A.O. is a Professor in the Department of Genetics and co-Director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School. Dr. Sinclair is co-founder of several biotechnology companies (Sirtris, Ovascience, Genocea, Cohbar, MetroBiotech, ArcBio, Liberty Biosecurity) and is on the boards of several others. He is also co-founder and co-chief editor of the journal Aging.
Life Biosciences was co-founded in 2017 by David A. Sinclair, PhD, AO, a professor in the Department of Genetics at Harvard Medical School, and Tristan Edwards, an investment professional who developed its innovative company structure.